Lydia Marcus1, Sumit Singh1, Jayne Ness1. 1. Department of Pediatrics (LM, JN), University of Alabama at Birmingham; and Pediatric Radiology Associates (SS), University of Alabama at Birmingham.
Abstract
OBJECTIVE: To observe whether cases of acute flaccid myelitis (AFM) before and since August 1, 2014, had important differences and to further characterize patients with AFM regarding clinical, laboratory, imaging, and treatment findings. METHODS: All pediatric patients with AFM at our institution were reviewed. Demographic, clinical, and diagnostic data were collected through medical record review. Patients with onset before August 1, 2014, and after that date were compared and when applicable compared with Centers for Disease Control and Prevention data. RESULTS: Sixteen patients were included, 6 in the pre-2014 and 10 in the post-2014 group. The mean age in the pre-2014 group was 7.4 years and in the post-2014 group was 6.4 years. Initial symptoms were similar in both groups, as were functional and motor abilities at disease nadir and the most recent follow-up. Post-2014 patients had a higher mean CSF white blood cell count (57) and neutrophil count (30%) compared with pre-2014 patients (3.2 and 0.5%, respectively). Eighty percent of post-2014 patients had positive enterovirus/rhinovirus testing, with 57% of specimens positive for enterovirus D68 (EV-D68). On acute imaging, a triad of brainstem, cervical cord gray matter involvement, and ventral nerve root/cauda equina (CE) thickening/enhancement was found in 5 patients. CONCLUSION: The groups had more similarities than differences but with a more inflammatory picture in the post-2014 patients. The constellation of cervical cord gray matter, brainstem, and nerve root/CE thickening should raise suspicion for AFM in the appropriate clinical setting. Most post-2014 patients had associated enterovirus infections, and over half tested for EV-D68 were positive. There was minimal clinical improvement in both groups despite various immunotherapies.
OBJECTIVE: To observe whether cases of acute flaccid myelitis (AFM) before and since August 1, 2014, had important differences and to further characterize patients with AFM regarding clinical, laboratory, imaging, and treatment findings. METHODS: All pediatric patients with AFM at our institution were reviewed. Demographic, clinical, and diagnostic data were collected through medical record review. Patients with onset before August 1, 2014, and after that date were compared and when applicable compared with Centers for Disease Control and Prevention data. RESULTS: Sixteen patients were included, 6 in the pre-2014 and 10 in the post-2014 group. The mean age in the pre-2014 group was 7.4 years and in the post-2014 group was 6.4 years. Initial symptoms were similar in both groups, as were functional and motor abilities at disease nadir and the most recent follow-up. Post-2014 patients had a higher mean CSF white blood cell count (57) and neutrophil count (30%) compared with pre-2014 patients (3.2 and 0.5%, respectively). Eighty percent of post-2014 patients had positive enterovirus/rhinovirus testing, with 57% of specimens positive for enterovirus D68 (EV-D68). On acute imaging, a triad of brainstem, cervical cord gray matter involvement, and ventral nerve root/cauda equina (CE) thickening/enhancement was found in 5 patients. CONCLUSION: The groups had more similarities than differences but with a more inflammatory picture in the post-2014 patients. The constellation of cervical cord gray matter, brainstem, and nerve root/CE thickening should raise suspicion for AFM in the appropriate clinical setting. Most post-2014 patients had associated enterovirus infections, and over half tested for EV-D68 were positive. There was minimal clinical improvement in both groups despite various immunotherapies.
Authors: Justin D Kreuter; Arti Barnes; James E McCarthy; Joseph D Schwartzman; M Steven Oberste; C Harker Rhodes; John F Modlin; Peter F Wright Journal: Arch Pathol Lab Med Date: 2011-06 Impact factor: 5.534
Authors: Keith Van Haren; Patrick Ayscue; Emmanuelle Waubant; Anna Clayton; Heather Sheriff; Shigeo Yagi; Rose Glenn-Finer; Tasha Padilla; Jonathan B Strober; Grace Aldrovandi; Debra A Wadford; Charles Y Chiu; Dongxiang Xia; Kathleen Harriman; James P Watt; Carol A Glaser Journal: JAMA Date: 2015 Dec 22-29 Impact factor: 56.272
Authors: Hooi-Ling Teoh; Shekeeb S Mohammad; Philip N Britton; Tejaswi Kandula; Michelle S Lorentzos; Robert Booy; Cheryl A Jones; William Rawlinson; Vidiya Ramachandran; Michael L Rodriguez; P Ian Andrews; Russell C Dale; Michelle A Farrar; Hugo Sampaio Journal: JAMA Neurol Date: 2016-03 Impact factor: 18.302
Authors: Gary R Nelson; Joshua L Bonkowsky; Elizabeth Doll; Michael Green; Gary L Hedlund; Kevin R Moore; James F Bale Journal: Pediatr Neurol Date: 2015-10-20 Impact factor: 3.372
Authors: J A Maloney; D M Mirsky; K Messacar; S R Dominguez; T Schreiner; N V Stence Journal: AJNR Am J Neuroradiol Date: 2014-11-20 Impact factor: 3.825
Authors: James J Sejvar; Adriana S Lopez; Margaret M Cortese; Eyal Leshem; Daniel M Pastula; Lisa Miller; Carol Glaser; Anita Kambhampati; Kayoko Shioda; Negar Aliabadi; Marc Fischer; Nicole Gregoricus; Robert Lanciotti; W Allan Nix; Senthilkumar K Sakthivel; D Scott Schmid; Jane F Seward; Suxiang Tong; M Steven Oberste; Mark Pallansch; Daniel Feikin Journal: Clin Infect Dis Date: 2016-06-17 Impact factor: 9.079
Authors: Daniel M Pastula; Negar Aliabadi; Amber K Haynes; Kevin Messacar; Teri Schreiner; John Maloney; Samuel R Dominguez; Emily Spence Davizon; Eyal Leshem; Marc Fischer; W Allan Nix; M Steven Oberste; Jane Seward; Daniel Feikin; Lisa Miller Journal: MMWR Morb Mortal Wkly Rep Date: 2014-10-10 Impact factor: 17.586
Authors: Shane C McAllister; Mark R Schleiss; Sophie Arbefeville; Marie E Steiner; Ryan S Hanson; Catherine Pollock; Patricia Ferrieri Journal: PLoS One Date: 2015-03-23 Impact factor: 3.240